These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37083142)

  • 1. Insights Into Perceptions and Gender Differences About Androgenetic Alopecia in an Observational Study of Commenters on the New York Times Oral Minoxidil Article.
    Desir N; Desai AD; Jafari A; Lipner SR
    J Cutan Med Surg; 2023; 27(4):399-400. PubMed ID: 37083142
    [No Abstract]   [Full Text] [Related]  

  • 2. Low-dose oral minoxidil for androgenetic alopecia is not associated with clinically significant blood-pressure changes: A retrospective study.
    Ong M; Do H; Ho B; Lipner SR
    J Am Acad Dermatol; 2024 Feb; 90(2):425-427. PubMed ID: 37839733
    [No Abstract]   [Full Text] [Related]  

  • 3. Androgenetic alopecia in transgender and gender diverse populations: A review of therapeutics.
    Gao JL; Streed CG; Thompson J; Dommasch ED; Peebles JK
    J Am Acad Dermatol; 2023 Oct; 89(4):774-783. PubMed ID: 34756934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Interest in Oral Minoxidil for Hair Loss Treatment Following Publication of August 2022 New York Times Article: A Google Trends Analysis.
    Desir N; Desai AD; Lipner SR
    Skin Appendage Disord; 2024 Feb; 10(1):46-49. PubMed ID: 38313574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgenetic alopecia: an evidence-based treatment update.
    Varothai S; Bergfeld WF
    Am J Clin Dermatol; 2014 Jul; 15(3):217-30. PubMed ID: 24848508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intradermal injections with 0.5% minoxidil for the treatment of female androgenetic alopecia: A randomized, placebo-controlled trial.
    Uzel BPC; Takano GHS; Chartuni JCN; Cesetti MV; Gavioli CFB; Lemes AM; Costa IMC
    Dermatol Ther; 2021 Jan; 34(1):e14622. PubMed ID: 33269529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of the treatment of male pattern hair loss.
    York K; Meah N; Bhoyrul B; Sinclair R
    Expert Opin Pharmacother; 2020 Apr; 21(5):603-612. PubMed ID: 32066284
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy and safety of a new 5% minoxidil formulation in male androgenetic alopecia: A randomized, placebo-controlled, double-blind, noninferiority study.
    Blume-Peytavi U; Issiakhem Z; Gautier S; Kottner J; Wigger-Alberti W; Fischer T; Hoffmann R; Tonner F; Bouroubi A; Voisard JJ
    J Cosmet Dermatol; 2019 Feb; 18(1):215-220. PubMed ID: 29659116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of oral minoxidil, finasteride, and dutasteride for treating androgenetic alopecia.
    Gupta AK; Talukder M; Williams G
    J Dermatolog Treat; 2022 Nov; 33(7):2946-2962. PubMed ID: 35920739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men.
    Olsen EA; Dunlap FE; Funicella T; Koperski JA; Swinehart JM; Tschen EH; Trancik RJ
    J Am Acad Dermatol; 2002 Sep; 47(3):377-85. PubMed ID: 12196747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral minoxidil use in androgenetic alopecia and telogen effluvium.
    Feaster B; Onamusi T; Cooley JE; McMichael AJ
    Arch Dermatol Res; 2023 Mar; 315(2):201-205. PubMed ID: 35244759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical utility and validity of minoxidil response testing in androgenetic alopecia.
    Goren A; Shapiro J; Roberts J; McCoy J; Desai N; Zarrab Z; Pietrzak A; Lotti T
    Dermatol Ther; 2015; 28(1):13-6. PubMed ID: 25112173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel topical combination of minoxidil and spironolactone for androgenetic alopecia: Clinical, histopathological, and physicochemical study.
    Abdel-Raouf H; Aly UF; Medhat W; Ahmed SS; Abdel-Aziz RTA
    Dermatol Ther; 2021 Jan; 34(1):e14678. PubMed ID: 33320406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Evaluation of the Clinical Efficacy of PRP-Therapy, Minoxidil, and Their Combination with Immunohistochemical Study of the Dynamics of Cell Proliferation in the Treatment of Men with Androgenetic Alopecia.
    Pakhomova EE; Smirnova IO
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral minoxidil treatment for hair loss: A review of efficacy and safety.
    Randolph M; Tosti A
    J Am Acad Dermatol; 2021 Mar; 84(3):737-746. PubMed ID: 32622136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of autologous platelet-rich plasma therapy versus topical Minoxidil in men with moderate androgenetic alopecia: a randomized open-label trial.
    Balasundaram M; Kumari R; Ramassamy S
    J Dermatolog Treat; 2023 Dec; 34(1):2182618. PubMed ID: 36800229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of combinational therapy using topical minoxidil and microneedling for the treatment of androgenetic alopecia: a systematic review and meta-analysis.
    Abdi P; Awad C; Anthony MR; Farkouh C; Kenny B; Maibach HI; Ogunyemi B
    Arch Dermatol Res; 2023 Dec; 315(10):2775-2785. PubMed ID: 37665358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between "5% minoxidil plus 2% flutamide" solution vs. "5% minoxidil" solution in the treatment of androgenetic alopecia.
    Faghihi G; Iraji F; Siadat AH; Saber M; Jelvan M; Hoseyni MS
    J Cosmet Dermatol; 2022 Oct; 21(10):4447-4453. PubMed ID: 35152531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical observation of basic fibroblast growth factor (bFGF) combined with minoxidil in the treatment of male androgenetic alopecia.
    Liu C; Zhao H; Zhang Y; Wu W
    J Cosmet Dermatol; 2022 Sep; 21(9):4053-4059. PubMed ID: 35037386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Randomized Control Trial Comparing the Efficacy of Platelet-Rich Plasma and 5% Topical Minoxidil for the Treatment of Androgenetic Alopecia.
    Asim M; Shah R; Sharif S; Ouellette S; Shah A; Rao B
    J Drugs Dermatol; 2023 Sep; 22(9):905-909. PubMed ID: 37683060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.